Data on the effects of The-Optimal-Lymph-Flow program on lymphedema symptoms in breast cancer survivors.

ABSTRACT: A substantial proportion of more than 50% of breast cancer survivors, who remain undiagnosed with lymphedema, encounter a daily struggle with the presence of multiple and concomitant lymphedema associated symptoms (i.e., lymphedema symptoms). The-Optimal-Lymph-Flow (TOLF) program was developed based on physiological-cognitive-behavioral principles to educate breast cancer survivors on effective self-care strategies. Physiologically, TOLF program was designed to stimulate lymphatic system to enhance lymph flow, thereby alleviating lymphedema symptoms and mitigating the risk and severity of lymphedema. The dataset presented in this article was obtained from a randomized clinical trial (RCT) that assessed the preventive effects of the TOLF program in improving lymphedema symptom experience an

SUBMITTER: Fu MR 

PROVIDER: S-EPMC10294092 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature